BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34117532)

  • 21. Reproducibility of histological cell type in high-grade endometrial carcinoma.
    Han G; Sidhu D; Duggan MA; Arseneau J; Cesari M; Clement PB; Ewanowich CA; Kalloger SE; Köbel M
    Mod Pathol; 2013 Dec; 26(12):1594-604. PubMed ID: 23807777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Standardized AgNOR analysis as a prognostic parameter in endometrial carcinoma, endometrioid type.
    Giuffrè G; Fulcheri E; Gualco M; Fedele F; Tuccari G
    Anal Quant Cytol Histol; 2001 Feb; 23(1):31-9. PubMed ID: 11233741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of myometrial invasion and TCGA groups of endometrial carcinoma.
    Raffone A; Travaglino A; Raimondo D; Neola D; Renzulli F; Santoro A; Insabato L; Casadio P; Zannoni GF; Zullo F; Mollo A; Seracchioli R
    Gynecol Oncol; 2021 Aug; 162(2):401-406. PubMed ID: 34088515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.
    Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I
    Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The complex triad of obesity, diabetes and race in Type I and II endometrial cancers: prevalence and prognostic significance.
    Ko EM; Walter P; Clark L; Jackson A; Franasiak J; Bolac C; Havrilesky L; Secord AA; Moore DT; Gehrig PA; Bae-Jump VL
    Gynecol Oncol; 2014 Apr; 133(1):28-32. PubMed ID: 24680588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A binary architectural grading system for uterine endometrial endometrioid carcinoma has superior reproducibility compared with FIGO grading and identifies subsets of advance-stage tumors with favorable and unfavorable prognosis.
    Lax SF; Kurman RJ; Pizer ES; Wu L; Ronnett BM
    Am J Surg Pathol; 2000 Sep; 24(9):1201-8. PubMed ID: 10976693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular Analysis of Mixed Endometrial Carcinomas Shows Clonality in Most Cases.
    Köbel M; Meng B; Hoang LN; Almadani N; Li X; Soslow RA; Gilks CB; Lee CH
    Am J Surg Pathol; 2016 Feb; 40(2):166-180. PubMed ID: 26492180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Poor interobserver reproducibility in the diagnosis of high-grade endometrial carcinoma.
    Gilks CB; Oliva E; Soslow RA
    Am J Surg Pathol; 2013 Jun; 37(6):874-81. PubMed ID: 23629444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucinous Adenocarcinoma of the Endometrium Compared With Endometrioid Endometrial Cancer: A SEER Analysis.
    Rauh-Hain JA; Vargas RJ; Clemmer J; Clark RM; Bradford LS; Growdon WB; Goodman A; Boruta DM; Schorge JO; del Carmen MG
    Am J Clin Oncol; 2016 Feb; 39(1):43-8. PubMed ID: 24390270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-grade endometrial carcinoma: serous and grade 3 endometrioid carcinomas have different immunophenotypes and outcomes.
    Alkushi A; Köbel M; Kalloger SE; Gilks CB
    Int J Gynecol Pathol; 2010 Jul; 29(4):343-50. PubMed ID: 20567148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic impact of morphometric nuclear grade of endometrial carcinoma.
    Salvesen HB; Iversen OE; Akslen LA
    Cancer; 1998 Sep; 83(5):956-64. PubMed ID: 9731900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathologic analysis of matched primary and recurrent endometrial carcinoma.
    Soslow RA; Wethington SL; Cesari M; Chiappetta D; Olvera N; Shia J; Levine DA
    Am J Surg Pathol; 2012 Dec; 36(12):1771-81. PubMed ID: 23154767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of solid growth in endometrioid endometrial adenocarcinoma.
    Akar S; Çelik ZE; Fındık S; İlhan TT; Ercan F; Çelik Ç
    Int J Clin Oncol; 2020 Jan; 25(1):195-202. PubMed ID: 31452018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytological nuclear atypia classification can predict prognosis in patients with endometrial cancer.
    Yamaguchi T; Kawahara A; Hattori S; Taira T; Abe H; Sanada S; Akiba J; Nishio S; Ushijima K; Kamura T; Kage M
    Cytopathology; 2015 Jun; 26(3):157-66. PubMed ID: 24827996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathologic analysis of 187 high-grade endometrial carcinomas of different histologic subtypes: similar outcomes belie distinctive biologic differences.
    Soslow RA; Bissonnette JP; Wilton A; Ferguson SE; Alektiar KM; Duska LR; Oliva E
    Am J Surg Pathol; 2007 Jul; 31(7):979-87. PubMed ID: 17592263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endometrial carcinoma recurrence according to race and ethnicity: An NRG Oncology/Gynecologic Oncology Group 210 Study.
    Felix AS; Brasky TM; Cohn DE; Mutch DG; Creasman WT; Thaker PH; Walker JL; Moore RG; Lele SB; Guntupalli SR; Downs LS; Nagel C; Boggess JF; Pearl ML; Ioffe OB; Deng W; Miller DS; Brinton LA
    Int J Cancer; 2018 Mar; 142(6):1102-1115. PubMed ID: 29063589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PIK3CA missense mutation is associated with unfavorable outcome in grade 3 endometrioid carcinoma but not in serous endometrial carcinoma.
    McIntyre JB; Nelson GS; Ghatage P; Morris D; Duggan MA; Lee CH; Doll CM; Köbel M
    Gynecol Oncol; 2014 Jan; 132(1):188-93. PubMed ID: 24262879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of endometrial cancer cells in the fallopian tube lumen is associated with adverse prognostic factors and reduced survival.
    Felix AS; Sinnott JA; Vetter MH; Rhoades J; Cohn DE; Backes FJ; Sherman ME; Suarez AA
    Gynecol Oncol; 2018 Jul; 150(1):38-43. PubMed ID: 29754740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reproducibility of lymphovascular space invasion (LVSI) assessment in endometrial cancer.
    Peters EEM; Bartosch C; McCluggage WG; Genestie C; Lax SF; Nout R; Oosting J; Singh N; Smit HCSH; Smit VTHBM; Van de Vijver KK; Bosse T
    Histopathology; 2019 Jul; 75(1):128-136. PubMed ID: 31155736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathologic characteristics and outcomes of endometrial Cancer patients with mismatch repair deficiency in the era of universal Lynch syndrome screening.
    Carr C; Son J; Yao M; Priyadarshini A; Marquard J; Vargas R; Michener C; AlHilli MM
    Gynecol Oncol; 2020 Dec; 159(3):712-720. PubMed ID: 33046272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.